FindTrial
Sign In

Effect of airway clearance device on function and quality of life in stable ICU patients.

Effect of Airphysio device on lung function, physical performance, functional capacity and Health related Quality of Life in ICU survivors: A Prospective, Double-blinded Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048008
Enrollment
36
Registered
2022-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J99- Respiratory disorders in diseasesclassified elsewhere

Interventions

Intervention1: AirPhysio device with ball bearing size of 17 mm and Conventional therapy: Use of Airphysio: Participants would be taught the correct technique to use the Airphysio device and they woul

Sponsors

MGM College of Physiotherapy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1)Patients who are spontaneously breathing or on non-invasive ventilatory support in intensive care unit (2) Patients extubated for more than 8 hours who were previously intubated (3) Patients showing radiographic changes of sputum retention, consolidation and pulmonary infiltrates (4) Patients who are above 18 years (5) Patient who consent to participate

Exclusion criteria

Exclusion criteria: (1) Patients who are hemodynamically unstable (2) Patients with untreated pneumothorax, emphysematous bullae, rib fractures etc (3) History of any recent major cardiac and neurosurgery (4) Patients who are tracheostomized during the ICU stay (5) Any neuro-musculoskeletal disorder that prevents them from performing the tests (6) Patients with cognitive impairment that prevents them from understanding the instructions (7) Patients who are agitated or sedated as assessed using Richmond Agitation Sedation Scale (RASS more than -1 or +1) (8) Participant who are not willing to participate

Design outcomes

Primary

MeasureTime frame
Primary outcome/s(1)Lung function : Pulmonary function (FEV1, FVC) , Respiratory muscle strength (Maximal Inspiratory Pressure, Maximal Expiratory Pressure), Chest expansion (at three levels namely axilla, nipple and xiphisternum) Sputum quantity would be assessed by measuring the sputum volume. (2)Physical performance: Short Physical Performance Battery test score (3)Functional capacity : Repetitions in 30 seconds Sit to Stand test (4)Quality of Life: EQ 5D 3L questionnaire score Timepoint: At Baseline At 4 weeks—

Secondary

MeasureTime frame
(1)Sarcopenia using SARC-calf scale. (2)Frailty using Fried Frailty Index. (3)ICU acquired weakness using Medical Research Council (MRC) sum score. Timepoint: At Baseline At 4 weeks—

Countries

India

Contacts

Public ContactVrushali Panhale

MGM College of Physiotherapy

shrutinair@mgmcopnm.edu.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026